RB
Revelation Biosciences Inc
🇺🇸XNAS.REVBUnited StatesHealthcare
$0.92USDup +0.01 (+1.1%)ClosedEnd of day1:49 AM
Price$0.92+0.01 (+1.1%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US76135L1017
- CUSIP
- 76135L101
Company
- Employees
- 8
- Headquarters
- San Diego, United States
- CEO
- Mr. James M. Rolke
Market
- Shares outstanding
- 4M
- Market cap
- $3.66M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $3.62M
- EPS LTM
- -$2.70calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.34calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$10.75M-27.03%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$9.44M+46.72%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.